Education
About Us
Working with TipRanks
Follow Us
Mustang Bio Inc (MBIO)
NASDAQ:MBIO
Total Valuation
Mustang Bio has a market cap or net worth of $5.08M. The enterprise value is -$10.53M.
Market Cap$5.08M
Enterprise Value-$10.53M
Share Statistics
Mustang Bio has 3,532,452 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,532,452
Owned by Insiders5.68%
Owned by Institutions1.29%
Financial Efficiency
Mustang Bio’s return on equity (ROE) is 4.07 and return on invested capital (ROIC) is 571.00%.
Return on Equity (ROE)4.07
Return on Assets (ROA)-1.69
Return on Invested Capital (ROIC)571.00%
Return on Capital Employed (ROCE)4.92
Revenue Per Employee0.00
Profits Per Employee-2.63M
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Mustang Bio is -3.44. Mustang Bio’s PEG ratio is -0.18.
PE Ratio-3.44
PS Ratio0.00
PB Ratio8.88
Price to Fair Value-14.00
Price to FCF-0.50
Price to Operating Cash Flow-4.28
PEG Ratio-0.18
Income Statement
In the last 12 months, Mustang Bio had revenue of 0.00 and earned -15.75M in profits. Earnings per share was -2.57.
Revenue0.00
Gross Profit0.00
Operating Income-16.25M
Pretax Income-15.75M
Net Income-15.75M
EBITDA-16.25M
Earnings Per Share (EPS)-2.57
Cash Flow
In the last 12 months, operating cash flow was -7.48M and capital expenditures 0.00, giving a free cash flow of -7.48M billion.
Operating Cash Flow-7.48M
Free Cash Flow-7.48M
Free Cash Flow per Share-2.12
Dividends & Yields
Mustang Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.30
52-Week Price Change-92.52%
50-Day Moving Average1.28
200-Day Moving Average7.93
Relative Strength Index (RSI)50.39
Average Volume (3m)742.26K
Important Dates
Mustang Bio upcoming earnings date is May 9, 2025, TBA Not Confirmed.
Last Earnings DateMar 24, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend Date―
Financial Position
Mustang Bio as a current ratio of 0.68, with Debt / Equity ratio of 0.00%
Current Ratio0.68
Quick Ratio0.68
Debt to Market Cap<0.01
Net Debt to EBITDA0.37
Interest Coverage Ratio3.25K
Taxes
In the past 12 months, Mustang Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Mustang Bio EV to EBITDA ratio is -2.97, with an EV/FCF ratio of -4.23.
EV to Sales0.00
EV to EBITDA-2.97
EV to Free Cash Flow-4.23
EV to Operating Cash Flow-4.23
Balance Sheet
Mustang Bio has $14.23M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$14.23M billion.
Cash & Marketable Securities$14.23M
Total Debt$0.00
Net Cash-$14.23M
Net Cash Per Share-$4.03
Tangible Book Value Per Share-$0.63
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Mustang Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast85.97%